application) The goal of this new Gastroenterology Research Training Program is to prepare M.D., Ph.D., or M.D./Ph.D. postdoctoral fellows for careers as independent investigators in academic Gastroenterology. A diverse and experienced faculty will provide the opportunity to learn contemporary methods of cellular and molecular biology or clinical research by mentorship in one of four broad areas: A) Injury, Fibrosis & Signaling; B) Cancer Biology & Immunology; C) Molecular Basis of Transport & Gene Therapy; or D) Patent‑based Clinical Investigation in Hepatobiliary and Gastrointestinal Diseases. The training will provide a solid foundation for future success in investigative Gastroenterology. To do so, expert faculty have been recruited from the Divisions of Gastroenterology, Liver Diseases, and Cardiology, and other Clinical and Basic Science Departments and Centers within the School of Medicine (the Dept of Pediatrics; Dept of Biochemistry, Developmental & Molecular Biology; Dept of Health Policy; the Immunobiology Center; the Institute for Gene Therapy and Molecular Medicine; and the Ruttenberg Cancer Center). Trainees will enter this program from one of four sources: 1) MDs or MD/PhDs who have completed 18 months to 2 years of training in adult clinical Gastroenterology, 2) MDs or MD/PhDs who have completed 1-2 years of Gastroenterology fellowship plus a year of clinical Hepatology fellowship; 3) MDs or MD/PhDs who have completed 1 year of a clinical Pediatric Gastroenterology fellowship; 4) PhD trainees who have completed a doctoral program in life sciences. Trainee candidates will be expected to devote a minimum of three years to training in either laboratory- or patient-based research. Each year this grant will support 4 trainees: 1-2 trainees at the PGY 5 level, 1-2 at the PGY 6 and one at the PGY 7 level. At least 90% of trainees time will be devoted to working in the laboratory or hospital setting on a specific, individualized research project under the guidance of one or more faculty mentors. In addition, all trainees will participate in weekly laboratory or clinical group meetings, attend relevant divisional, departmental and institutional research‑oriented conferences, and will enroll in specifically designed coursework in laboratory or clinical investigative methods. This integrated proposal emphasizing translational research emerges from a dynamic, rapidly growing academic institution, one that has created an ideal environment for equipping outstanding clinicians and biomedical trainees to elucidate and treat gastrointestinal diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
1T32DK007792-01
Application #
6215944
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
2001-05-01
Project End
2006-01-31
Budget Start
2001-05-01
Budget End
2002-01-31
Support Year
1
Fiscal Year
2001
Total Cost
$101,748
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Wooden, Benjamin; Goossens, Nicolas; Hoshida, Yujin et al. (2017) Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases. Gastroenterology 152:53-67.e3
Klepper, Arielle; Eng, Francis J; Doyle, Erin H et al. (2017) Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cells. Hepatology 66:357-370
Hicks, Daniel F; Goossens, Nicolas; Blas-García, Ana et al. (2017) Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells. Sci Rep 7:42563
Tovar, Victoria; Cornella, Helena; Moeini, Agrin et al. (2017) Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut 66:530-540
Mosoian, Arevik; Zhang, Lumin; Hong, Feng et al. (2017) Frontline Science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS. J Leukoc Biol 101:1083-1090
Cohen, Louis J; Esterhazy, Daria; Kim, Seong-Hwan et al. (2017) Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 549:48-53
Bollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina et al. (2017) Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut 66:1286-1296
Shtraizent, Nataly; DeRossi, Charles; Nayar, Shikha et al. (2017) MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect. Elife 6:
Abou-Alfa, Ghassan K; Andersen, Jesper B; Chapman, William et al. (2016) Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference. J Gastrointest Oncol 7:819-827
Chu, John; Vila-Farres, Xavier; Inoyama, Daigo et al. (2016) Discovery of MRSA active antibiotics using primary sequence from the human microbiome. Nat Chem Biol 12:1004-1006

Showing the most recent 10 out of 42 publications